Kumasi Cohort Study (KCS)
Efficacy of First and Second Line ART in HIV Patients Treated at the Komfo Anokye Teaching Hospital, Kumasi
Sponsor: Bernhard Nocht Institute for Tropical Medicine
Listed as NCT01853657, this NA trial focuses on HIV and remains ongoing. Sponsored by Bernhard Nocht Institute for Tropical Medicine, it has been updated 8 times since 2012, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Aug 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Sep 2021 — Aug 2023 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Unknown Status NA
▶ Show 3 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Feb 2020 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Jun 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bernhard Nocht Institute for Tropical Medicine
- Komfo Anokye Teaching Hospital
- Kumasi Centre for Collaborative Research (KCCR)
- Kwame Nkrumah University of Science and Technology
- Universitätsklinikum Hamburg-Eppendorf
For direct contact, visit the study record on ClinicalTrials.gov .